Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospital Units | 1 | 2020 | 30 | 0.720 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.710 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 54 | 0.700 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 80 | 0.690 |
Why?
|
| Computed Tomography Angiography | 2 | 2021 | 154 | 0.680 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 157 | 0.660 |
Why?
|
| Intestinal Neoplasms | 2 | 2024 | 68 | 0.450 |
Why?
|
| Neuroendocrine Tumors | 2 | 2024 | 124 | 0.410 |
Why?
|
| Stomach Neoplasms | 2 | 2024 | 288 | 0.380 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2023 | 153 | 0.360 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 684 | 0.310 |
Why?
|
| Octreotide | 2 | 2024 | 27 | 0.300 |
Why?
|
| Receptors, Peptide | 2 | 2024 | 25 | 0.300 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2024 | 142 | 0.270 |
Why?
|
| X-linked Nuclear Protein | 1 | 2024 | 10 | 0.240 |
Why?
|
| Co-Repressor Proteins | 1 | 2024 | 25 | 0.240 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 123 | 0.230 |
Why?
|
| Organometallic Compounds | 1 | 2024 | 137 | 0.220 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2021 | 20 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 665 | 0.180 |
Why?
|
| Angiography | 1 | 2021 | 208 | 0.180 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 59 | 0.180 |
Why?
|
| Fluoroscopy | 1 | 2020 | 127 | 0.180 |
Why?
|
| Workflow | 1 | 2020 | 81 | 0.170 |
Why?
|
| Workload | 1 | 2020 | 129 | 0.170 |
Why?
|
| Neuroblastoma | 1 | 2021 | 400 | 0.150 |
Why?
|
| Medicare | 1 | 2021 | 427 | 0.150 |
Why?
|
| Retrospective Studies | 4 | 2024 | 9159 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 1130 | 0.120 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2024 | 98 | 0.110 |
Why?
|
| Mutation | 1 | 2024 | 4164 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 2368 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2023 | 196 | 0.090 |
Why?
|
| Humans | 8 | 2024 | 89785 | 0.070 |
Why?
|
| Aged | 4 | 2024 | 19212 | 0.070 |
Why?
|
| Prognosis | 2 | 2024 | 3785 | 0.070 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2024 | 79 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6778 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2024 | 196 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 337 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2023 | 310 | 0.050 |
Why?
|
| Histiocytes | 1 | 2021 | 22 | 0.050 |
Why?
|
| Research Report | 1 | 2021 | 44 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2021 | 222 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2021 | 46 | 0.050 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 51 | 0.050 |
Why?
|
| Middle Aged | 3 | 2024 | 26080 | 0.050 |
Why?
|
| Radiology, Interventional | 1 | 2021 | 69 | 0.050 |
Why?
|
| Male | 3 | 2024 | 42582 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1350 | 0.040 |
Why?
|
| Female | 3 | 2024 | 46494 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 26767 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1221 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2024 | 8243 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 2505 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7083 | 0.020 |
Why?
|